{"disease":{"id":"pomes-syndrome","name":"pomes syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03879382","title":"Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R POMES","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":10,"lead_sponsor_name":"Hrain Biotechnology Co., Ltd.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}